Plant immunity consists of two arms: pathogen-associated molecular pattern (PAMP)-triggered immunity (PTI), induced by surface-localized receptors, and effector-triggered immunity (ETI), induced by intracellular receptors. Despite the little structural similarity, both receptor types activate similar responses with different dynamics.
Introduction
The recognition of pathogenic microorganisms is the first crucial step in the immune response of plants aimed at the inhibition of pathogen ingress. Typically, the plant immune system is represented by two distinct arms (Jones & Dangl, 2006; Dodds & Rathjen, 2010) . The first arm is initiated on perception of pathogen-associated molecular patterns (PAMPs) by cell surfacelocalized pattern recognition receptors (PRRs), leading to PAMP-triggered immunity (PTI). Plant PRRs are either receptor-like kinases (RLKs) or receptor-like proteins (Boutrot & Zipfel, 2017) . Successful pathogens cause disease using effector molecules that interfere with PTI. Bacterial effectors are often proteins secreted into plant cells via the type III secretion system. For example, the pathogen effector AvrRpm1 from Pseudomonas syringae pv maculicola, as well as AvrB and AvrRpt2 from Pseudomonas syringae pv tomato (Pto), target the Arabidopsis membrane-localized protein RPM1-INTERACTING PROTEIN-4 (RIN4), which is a regulator of PTI (Chung et al., 2014; Lee et al., 2015) . Phosphorylation of RIN4 by AvrB through RPM1-INDUCED PROTEIN KINASE (RIPK) and the degradation of RIN4 by AvrRpt2 are recognized by the intracellular nucleotide-binding domain leucine-rich repeat (NLR)-type immune receptors RESISTANCE TO P. SYRINGAE PV MACULICOLA-1 (RPM1) and RESISTANT TO P. SYRINGAE-2 (RPS2), respectively (Spoel & Dong, 2012; Khan et al., 2016) . The activation of NLRs results in effector-triggered immunity (ETI).
ETI is considered to be a stronger and faster response than PTI (Jones & Dangl, 2006) . PTI and ETI share some signaling components, such as Ca 2+ and mitogen-activated protein kinase (MAPK) cascades (Tsuda et al., 2013; Yu et al., 2017) . In addition, they share immune responses, such as transcriptional reprogramming, the generation of apoplastic reactive oxygen species (ROS), and the production and secretion of antimicrobial compounds. However, the activated immune responses during ETI are generally more prolonged and robust than those during PTI (Dodds & Rathjen, 2010; Tsuda & Katagiri, 2010; Thomma et al., 2011) . These observations suggest that the same signaling components or enzymes are similarly regulated during PTI and ETI, whereas the dynamics and strength of the activation are different. However, it is currently unclear how NLRs transduce the signal downstream and how PRRs and NLRs, localized to different cellular compartments, activate similar components to induce related defense outputs.
ROS have various roles in immune signaling and are produced by RESPIRATORY BURST OXIDASE HOMOLOG D (RBOHD) during both PTI and ETI, but with different kinetics: ROS accumulation is only detectable hours after activation of RPM1 and RPS2 by cognate effectors (Torres et al., 2002) . Recent research has clarified the molecular mechanisms underlying signaling from PAMP recognition to the ROS burst. On recognition of the flagellin 22 (flg22) peptide, derived from bacterial flagellin, the PRR FLAGELLIN SENSING-2 (FLS2) associates with its coreceptor RLK BRI1-ASSOCIATED RECEPTOR KINASE-1 (BAK1). The FLS2-BAK1 interaction induces the phosphorylation and activation of both proteins, resulting in the phosphorylation of the receptor-like cytoplasmic kinase (RLCK) BOTRYTIS-INDUCED KINASE-1 (BIK1). Subsequently, BIK1 directly phosphorylates RBOHD, responsible for the apoplastic ROS burst observed within minutes after PRR activation (Kadota et al., 2014 (Kadota et al., , 2015 Li et al., 2014) . Although phosphorylation-mediated activation of RBOHD has been well studied during PTI, it is currently unknown whether similar RBOHD phosphorylation patterns are induced during ETI.
To gain insights into ETI signaling, we have previously analyzed the changes in abundance of plasma membrane-localized proteins during ETI mediated by RPS2 using transgenic Arabidopsis lines expressing the bacterial effector avrRpt2 under a dexamethasone (Dex)-inducible promoter (McNellis et al., 1998; Elmore et al., 2012) . Among the significantly upregulated proteins after activation of RPS2, many proteins belong to the protein kinase superfamily, suggesting that protein phosphorylation plays a crucial role during RPS2-mediated ETI. However, phosphorylation-based regulation of immune regulatory networks during ETI is still largely unknown. examined quantitative changes in the phosphoproteome of Arabidopsis infiltrated with Pto DC3000 (avrRpm1) and found that only one protein (the large subunit of Rubisco) was highly phosphorylated after activation of RPM1, but the exact phosphorylation site was not elucidated. The low success rate of phosphosite identification when avirulent pathogens are used may be a result of the difficulty in synchronously inducing only ETI in sufficient cells without activating PTI.
Here, we employed an unbiased phosphoproteomic screen using an avrRpt2-inducible expression system, and successfully identified differentially phosphorylated membrane-associated proteins during the early stages of ETI. Interestingly, several RPS2-regulated phosphorylation sites overlap with sites differentially phosphorylated during PTI as published previously. Our results suggest that these common phosphorylation sites may be convergent points of both immune signaling arms. For example, PAMP-responsive RBOHD phosphorylation sites, S343 and S347, are also highly phosphorylated during ETI. Functional analyses revealed that these RBOHD sites are required for ROS production during both PTI and ETI, as well as for full resistance against avirulent Pto strains and a virulent necrotrophic fungus. Our study provides important phosphoproteomic data contributing to our understanding of the ETI signaling network and showing commonalities with and differences from the PTI signaling network.
Materials and Methods

Plant materials and growth conditions
Arabidopsis plants were grown in a controlled growth chamber under 70% relative humidity at 23°C and a light intensity of 85 lmol m À2 s À1 . A 10-h light and 14-h dark photoperiod was applied. Plant genotypes are described in Supporting Information Methods S1.
Phosphopeptide sample preparation
In each of three biological replicates, flats of Dex:avrRpt2 and control rpm1rps2/Dex:avrRpt2 Arabidopsis plants were grown for 5 wk. Subsequently, plants were sprayed with an aqueous solution containing 30 lM Dex and 0.025% Silwett L-77. In total, 10 g of leaf tissue was harvested per sample at 0, 1 and 3 h after spraying with Dex and flash-frozen in liquid nitrogen. Details of the phosphopeptide enrichment method are described in Methods S1.
LC-MS/MS and data analysis
Phosphopeptide samples were separately analyzed by a QExactive Plus Orbitrap mass spectrometer (Thermo Fisher Scientific, Waltham, MA, USA) LC-MS/MS for a total of 18 runs at the UC Davis Proteomics Core. LC-MS/MS settings and specifics are described in Methods S1. LC-MS/MS raw files were analyzed using the MAXQUANT (v.1.5.1.0) and PERSEUS (v.1.5.0.15) software packages (Tyanova et al., 2016a,b) . Raw data files were searched against a FASTA database containing the Arabidopsis thaliana proteome. Statistical analysis is described in Methods S1. Raw data and search engine results are available at the PRIDE ProteomeXchange website under accession number PXD010440 (Vizcaino et al., 2013) . Details of quantified phosphosites are shown in Tables S1-S4. Search parameters for MAXQUANT can be found in Table S5 . Highest intensities and spectra per phosphosite are reported in Table S6 .
Selected reaction monitoring (SRM) and data analysis FLAG-RBOHD proteins extracted from rbohD/35S:FLAGRbohD were immunoprecipitated with anti-FLAG antibody and separated by sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (NuPAGe ® ; Invitrogen, Carlsbad, CA, USA). After staining with Coomassie Brilliant Blue G-250 (CBB; SimplyBlue TM stain; Invitrogen), the proteins were cut out and digested with trypsin, as described previously (Kadota et al., 2014) . The intensities of phosphopeptides were normalized by the intensity of control nonphosphorylated RBOHD peptides. Details are provided in Methods S1; the transitions used for SRM are presented in Table S7 .
Disease assays
Bacterial disease assays were performed as described previously (Kim et al., 2005) . Plectosphaerella cucumerina BMM (PcBMM) disease assays and fungal biomass determination were performed as described previously (Torres et al., 2013) . A detailed description is described in Methods S1. The primers used for quantitative PCR analysis are shown in Table S8 .
ROS staining and measurements
The ROS staining protocol was adapted from an earlier described 3,3 0 -diaminobenzidine (DAB, Sigma) staining protocol (Thordal-Christensen et al., 1997) and is described in detail in Methods S1.
Results
An unbiased phosphoproteomic screen reveals ETIdependent differential phosphorylation sites
Previous phosphoproteomic studies have identified a large number of differentially phosphorylated proteins during PTI (Benschop et al., 2007; N€ uhse et al., 2007; Rayapuram et al., 2014; Mattei et al., 2016) . To identify differential phosphorylation sites during ETI, we used Dex:avrRpt2 Arabidopsis lines to activate RPS2 synchronously and to effectively eliminate the effect of any bacterial PAMPs which would activate PTI. It has been reported that AvrRpt2 can also weakly activate RPM1 (Kim et al., 2009 ). Therefore, we generated an rpm1rps2/Dex:avrRpt2 control line which does not induce ETI (Fig. S1a) . We confirmed that both lines showed comparable Dex-inducible avrRpt2 transcript expression and RIN4 protein degradation (Fig. S1b,c) . By comparing the two lines, we aimed to identify differentially phosphorylated sites that are dependent on the activation of RPS2.
We decided to analyze membrane fractions because RPS2 associates to the plasma membrane and we expected that early phosphorylation events would occur at the plasma membrane (Qi & Katagiri, 2009 ). In addition, membrane fractions are less complex in protein composition compared with total protein fractions, thus enabling us to perform label-free quantification using single MS runs. Before or after treatment with Dex for 1 or 3 h, total membrane fractions of Dex:avrRpt2 and rpm1rps2/Dex: avrRpt2 were digested with trypsin, followed by phosphopeptide enrichment using magnetic TiO 2 beads and identification by MS (Fig. 1) . Label-free quantitative analysis followed by ANOVA (P ≤ 0.05) revealed 264 unique phosphorylation sites to be statistically significantly changed in abundance in at least one condition (Table S1 ). These sites included (1) those regulated by activated RPS2, (2) those regulated by AvrRpt2 independent of RPS2 activation, (3) those regulated by Dex treatment independently of AvrRpt2 and/or RPS2, and (4) those differentially phosphorylated solely depending on the plant genotype. To extract differentially phosphorylated sites after avrRpt2 expression and remove the sites dependent only on plant genotypes, we performed t-test between time points 0 and 1 h, and 0 and 3 h, after Dex treatment in each genotype (P ≤ 0.05). We found that 111 unique sites were significantly differentially phosphorylated after Dex treatment at 1 or 3 h in Dex:avrRpt2. Twelve sites were highly phosphorylated after Dex treatment in both lines, but only two of these phosphorylation sites (S280 and S283 of PIP2B) were phosphorylated to a similar degree in both lines, suggesting that, for these sites, the increased phosphorylation at these two sites is caused by avrRpt2 expression or Dex treatment independently on RPS2 and AvrRpt2. The other 10 sites were phosphorylated in rpm1rps2/Dex:avrRpt2, but the ratio increase was at least two-fold greater in Dex:avrRpt2. These data suggest that, although phosphorylation at these 10 sites can potentially also be induced by AvrRpt2 or Dex application alone, phosphorylation of these sites is significantly enhanced on RPS2 activation (Table S1 ). In summary, we identified 109 sites differentially phosphorylated upon activation of RPS2. Of these 109 sites, 84 sites were increased in phosphorylation ( Fig. 2a ; Table S2 ) and 25 sites were decreased in phosphorylation ( Fig. 2b ; Table S3 ). Hereafter, we call these sites 'RPS2-regulated phosphorylation sites'. The majority of the upregulated phosphorylation sites are statistically significantly phosphorylated at 3 h after Dex spray, whereas the majority of downregulated phosphorylation sites are dephosphorylated at 1 h after Dex spray. We also investigated the identified phosphosites for MAPK and CALCIUM-DEPENDENT PROTEIN KINASE (CPK) phosphorylation motifs. We found that 32 and 10 phosphosites of 84 RPS2-upregulated phosphosites contain MAPK and CPK phosphorylation motifs, respectively (Table S2) .
Changes in the phosphorylation intensities on proteins could potentially also be explained by alterations in protein abundance or a change in protein localization. Therefore, we also analyzed total protein abundance in nonphosphopeptide-enriched fractions of the samples (Tables S1-S3 ). These data revealed that the changes in abundance of some phosphorylation sites could be attributed to the changes in protein abundance at the membrane. We could not detect all proteins for which phosphorylated residues were quantified, potentially because of the low abundance of these proteins. Consequently, changes in phosphorylation intensities of such low-abundance proteins could be the result of changes in protein abundance at the membrane with a similar level of phosphorylation after AvrRpt2 expression, changes in phosphorylation status after AvrRpt2 expression, or both.
Of note, even for the abundant proteins whose protein levels were detectable in the nonphosphopeptide-enriched samples, we could not fully exclude the possibility that a decrease in phosphorylation would be caused by selective degradation and/or altered localization of the phosphorylated protein.
Overlap in RPS2-and FLS2-induced phosphorylation sites
We found that 14 of 109 RPS2-regulated phosphorylation sites overlapped with previously identified flg22/FLS2-regulated phosphorylation sites (the phosphorylation at 11 sites was increased and that at three sites was decreased during both ETI and PTI) ( Table 1 ). As our phosphoproteomic strategy is not fully identical in approach to previous studies aimed at the identification of PAMP-regulated phosphorylation sites (Benschop et al., 2007; N€ uhse et al., 2007) , there may, in fact, be more overlap in phosphorylation sites regulated during both ETI and PTI. Examples of such overlapping sites are the phosphorylation sites in RBOHD, the ABC-transporter PENETRATION-3 (PEN3), the plasma membrane-localized calcium-ATPase AUTOINHIBITED Ca 2+ ATPASE-8 (ACA8) and the noncanonical Ga protein EXTRA-LARGE GTP-BINDING PROTEIN-2 (XLG2) (Benschop et al., 2007; N€ uhse et al., 2007; Tables 1, S4) . For most of these sites, total protein levels did not change significantly during RPS2 activation (Tables 1, S4 ). Below, we discuss these proteins in more detail.
RPS2 signaling strongly induced RBOHD phosphorylation at residues S163, S343 and S347 ( Fig. 2 ; Table 1 ). We also found induced phosphorylation at S33. However, care must be taken for this site, because RBOHD protein amounts increased to a similar extent as S33 phosphorylation upon RPS2 activation (Table S4) . Treatment with flg22, elf18 or chitin induces RBOHD phosphorylation at residues S163, S343 and S347, and these phosphorylated residues are required for full ROS production on PTI (Dubiella et al., 2013; Kadota et al., 2014; Li et al., 2014) . In particular, BIK1 phosphorylates RBOHD residues S343 and S347, and CPKs phosphorylate RBOHD residues S163 and, possibly, S347 during PTI. Recently, it was found that the MAP4K SIK1 is also involved in the full phosphorylation on S339 and S347 during PTI (M. Zhang et al., 2018) .
PEN3 is involved in nonhost resistance against the powdery mildew fungus Blumeria graminis f. sp. hordei (Bgh), but also has broader roles in resistance, including ETI signaling (Johansson et al., 2014) . PEN3 delivers indole glucosinolates to the apoplast at the plasma membrane (Kwon et al., 2008) . In addition, the pen3 mutant shows defects in cell death induction by avirulent bacteria, such as Pto DC3000 (avrRpm1) and Pto DC3000 (avrRps4), and an avirulent isolate of the oomycete Hyaloperonospora arabidopsis (Hpa) (Piasecka et al., 2015) . We found that RPS2 signaling induced phosphorylation of PEN3 at S40 and S45, which are also reported as flg22/FLS2-inducible phosphorylation sites (Tables 1, S4 ). Moreover, these sites have been shown recently to be required for the function of PEN3 in immunity against Bgh (Underwood & Somerville, 2017) . These results suggest that PEN3 is activated during both PTI and ETI by phosphorylation at common residues, which may be required for the transport of indole glucosinolates or other antimicrobials to restrict pathogen colonization.
ACA8 forms a protein complex with FLS2 and is involved in flg22-inducible Ca 2+ signaling (Frei dit Frey et al., 2012) . flg22 treatment/perception induces phosphorylation at ACA8 S22, and this N-terminal phosphorylation is important for the interaction of ACA8 with CALMODULIN (CaM), leading to ACA8 activation (Giacometti et al., 2012) . We found that RPS2 activation similarly induced S22 phosphorylation (Tables 1, S4) , suggesting CaM-mediated activation of ACA8 during both PTI and ETI. Interestingly, CPK16 can phosphorylate S22 of ACA8 in vitro (Giacometti et al., 2012) , suggesting a role of CPK16 in Table S1 ): black, sites for which the protein levels were not significantly altered amongst treatments; magenta, sites for which protein levels were significantly increased in Dex:avrRpt2 plants on application of dexamethasone (Dex); green, sites for which protein levels were significantly decreased in rpm1rps2/Dex:avrRpt2 plants on Dex application; orange, sites for which no peptides were detected in total protein samples; black stars, the phosphorylation sites upregulated in both lines after Dex treatment. φ-X-X-X-X-S/T-X-B Phosphorylation data after flg22 treatment were extracted from the articles indicated. The data are shown as the fold change. For the data of RPS2, the fold change of the phosphorylated sites was calculated based on raw intensities. The fold change of the protein levels was calculated based on the Maxquant label-free quantification intensities transformed to raw intensities (see Supporting Information Methods S1). Significantly differentially phosphorylated sites with a ratio higher than 1.5 or lower than 0.5 were kept; see also Tables S1-S3.   1 The phosphorylation ratio at 10 min after flg22 treatment (Benschop et al., 2007) . The best phosphorylation ratio at 7 min after flg22 treatment of five replicates is shown (N€ uhse et al., 2007) . Phosphorylated but not quantified (Liang et al., 2016) .
4 Double phosphorylated peptide.
5
Calculated based on singly phosphorylated phosphopeptide intensities (Table S1 Multiplicity = __1).
6
Calculated based on doubly phosphorylated phosphopeptide intensities (Table S1 Multiplicity = __2).
7
CPK phosphorylation motif: φ-X-X-X-X-S/T-X-B (S/T is the phosphorylated residue, B is a basic residue, φ is a hydrophobic residue, X is any residue) Hernandez Sebastia et al., 2004) . (Costa et al., 2017) . However, the role of ACA8, as well as CPK16, CIPK9 and CBL1, during ETI remains to be elucidated.
MAPK phosphorylation motif S/T-P (S/T is the phosphorylated residue
XLG2 is a member of the heterotrimeric G proteins and participates in signaling with the Gb protein GTP-BINDING PROTEIN BETA-1 (AGB1), and the Gc proteins G PROTEIN GAMMA-SUBUNIT-1 (AGG1) and AGG2 (Zhu et al., 2009; Chakravorty et al., 2015) . We found an increase in S23 and S169 phosphorylation of XLG2 after activation of RPS2, but we could not detect XLG2 total protein in the nonphosphopeptideenriched fractions (Table 1 ). XLG2 interacts with FLS2 and BIK1, and functions to attenuate the proteasome-mediated degradation of BIK1 (Liang et al., 2016; Wang et al., 2018) . After flg22 recognition, XLG2 is phosphorylated by BIK1, dissociates from AGB1 and the phosphorylated XLG2 enhances ROS production, possibly through the modulation of RBOHD (Liang et al., 2016; Wang et al., 2018) . Multiple sites of XLG2, including S23 and S169, are phosphorylated in flg22-treated protoplast cells (Liang et al., 2016) , suggesting that these are common phosphorylation sites during both PTI and ETI. Although the roles of these phosphorylation sites need to be elucidated further, our results suggest that XLG2 phosphorylation may also contribute to RBOHD-mediated ROS production during ETI.
RPS2 and FLS2 activation results in dephosphorylation of H + -ATPases
Plasma membrane H + -ATPases (AHAs) generate the protonmotive force across the plasma membrane necessary to activate ion and metabolite transport (Morsomme & Boutry, 2000) . AHAs also play a pivotal role in the opening of stomata, which are important entry sites for bacteria during natural infection (Yamauchi et al., 2016) . We found that RPS2 activation resulted in C-terminal dephosphorylation of AHA1 at T948 and at homologous sites of AHA2 (T947) and AHA4 (T955) (Figs 2, S2a; Tables 1, S4 ). Interestingly, FLS2 activation similarly induces dephosphorylation of AHA1 at T948 and AHA2 at T947 (N€ uhse et al., 2007) .
RPS2 regulates changes in phosphorylation status of defense-associated proteins
In addition to the overlapping PTI and ETI phosphorylation sites, we discovered a set of novel sites involved in RPS2 signaling on a variety of proteins, including defense-associated proteins. These sites are on proteins such as the kinase RIPK and PLASMA MEMBRANE INTRINSIC PROTEIN (PIP) aquaporins ( Fig. 2; Table S2 ).
Currently, the involvement of RIPK in the RPS2 signaling pathway is unknown (Liu et al., 2011) . However, we found that RPS2 activation induced dramatic phosphorylation of RIPK at the residue S433 ( Fig. 2; Table S2 ). The importance of RIPK phosphorylation during RPS2-mediated ETI requires future investigation as we did not detect RIPK total protein in the nonphosphopeptide-enriched fractions (Table S1) .
PIP aquaporins can transport water and H 2 O 2 between the apoplast and cytoplasm. C-terminal PIP phosphosites are strongly conserved among PIPs and required for their activation (Maurel et al., 2015) . Arabidopsis PIP1E transports apoplastic H 2 O 2 produced by RBOH after PAMP treatment to the cytoplasm (Tian et al., 2016) . This transport is required for the full activation of immune responses, including pathogenesis-related gene expression and callose deposition. PIP2A is also required for the intracellular accumulation of H 2 O 2 , as well as stomatal closure, induced by PAMPs (Rodrigues et al., 2017) . We found that several conserved residues at the C-terminal region of PIPs, such as S279 and S282 of PIP2D and PIP2E, and S273, S276 and S279 of PIP3, were highly phosphorylated on avrRpt2 expression in the presence of RPS2 (Figs 2, S2b ; Table S4 ). PIPs may be activated during ETI and transport both water and H 2 O 2 to the cytoplasm in a similar manner as during PTI. Recently, the importance of an aqueous apoplast for successful bacterial proliferation was shown (Xin et al., 2016) . In line with our results, AvrRpt2-induced ETI failed to induce water soaking (Xin et al., 2016) . It is tempting to speculate that the activation of PIPs contributes to reducing the aqueous space in the apoplast, thereby suppressing bacterial growth.
In addition to the upregulated phosphorylations, the activation of RPS2 resulted in dephosphorylation of the auxin transporter PIN-FORMED-3 (PIN3) at T279 and, possibly, PIN4 at T276 and PIN7 at T282, reflecting a possible crosstalk of ETI signaling and auxin signaling (Figs 2, S2c; Table S3 ). Interestingly, AvrRpt2 promotes the virulence of Pto DC3000 by stimulating the turnover of key auxin transcription repressors Aux/IAA, thereby activating auxin responses (Cui et al., 2013) . Although the role of the phosphorylation of these PIN residues needs to be elucidated further, RPS2-mediated dephosphorylation of PINs may change the localization of these auxin transporters, thereby altering auxin transport to suppress AvrRpt2-induced auxin signaling (Lofke et al., 2013) .
Interestingly, we also found AvrRpt2 itself to be phosphorylated at S97. However, we only observed S97 phosphorylation in the absence of the RPM1 and RPS2 receptors ( Fig. 2; Table S1 ). This suggests a possible involvement of AvrRpt2 phosphorylation for its virulent function, and suppression of AvrRpt2 phosphorylation during ETI signaling. However, we could not correlate this phosphorylation to AvrRpt2 protein levels, as we did not detect AvrRpt2 protein in unenriched protein samples by MS (Table S1 ). Instead, we detected a similar avrRpt2 gene expression pattern by semi-quantitative PCR (Fig. S1b) .
Phosphorylation of common RBOHD residues is required for ROS production during ETI
We hypothesize that the common PTI and ETI phosphorylation targets are potential convergent points of immune signaling and should therefore tightly regulate the activity of such proteins. As RBOHD contains several such common phosphosites, we sought to clarify the importance of these common RBOHD sites during PTI and ETI. To confirm that RBOD phosphorylation during ETI identified in our large-scale screen also occurs on bacterial infection, we syringe inoculated leaves of rbohD plants, complemented with 35S:FLAG-RBOHD, with Pto DC3000 EV (empty vector), Pto DC3000 (avrRpm1), Pto DC3000 (avrRpt2) or 10 mM MgCl 2 solution. We collected the leaves at 6 h after inoculation, because avirulent effector-mediated transcriptional changes are most highly induced at 6 h after infiltration with Pto DC3000 (avrRpm1) and Pto DC3000 (avrRpt2) (Mine et al., 2018) , and ROS are also actively produced at this time point (Torres et al., 2002) . After collecting the infiltrated leaves, FLAG-RBOHD protein was immunopurified and individual RBOHD phosphorylation sites were quantified by SRM MS on a triple quadrupole mass spectrometer. Both avirulent strains, Pto DC3000 (avrRpm1) and Pto DC3000 (avrRpt2), but not virulent Pto DC3000 EV or 10 mM MgCl 2 solution, induced phosphorylation at residues S343 and S347 (Fig. 3) . By contrast with our large-scale phosphoscreen, residue S163 was not highly phosphorylated 6 h after bacterial infection, suggesting that S163 phosphorylation may be transient on bacterial infection. In addition, the phosphorylation at residue S39, which is a BIK1-dependent flg22-induced RBOHD phosphorylation site (Kadota et al., 2014; Li et al., 2014) , was not detectable after infection with any of the bacteria under the conditions tested.
To investigate the role of RBOHD phosphorylation sites S343 and S347 on ROS production during ETI, we generated transgenic Arabidopsis rbohd mutant lines expressing either the wildtype (WT) or the S343A/S347A variant of FLAG-tagged RBOHD driven by its endogenous promoter. Both lines expressed comparable amounts of RBOHD protein (Fig. 4a) and did not exhibit any obvious morphological growth phenotypes (Fig. S3a) . Interestingly, S343A/S347A plants lost the ability to induce ROS production after infiltration with avirulent Pto DC3000 (avrRpm1) or Pto DC3000 (avrRpt2), whereas WT plants induced a strong H 2 O 2 accumulation (Fig. 4b) . Moreover, the S343A/S347A plants did not show ROS production on flg22 treatment (Fig. S3b) (N€ uhse et al., 2007) . These results demonstrate that S343 and S347 are required for ROS production during both PTI and ETI. Importantly, S343 and S347 are highly conserved in RBOHD homologs amongst different plants (Fig. S4) , as well as in most Arabidopsis RBOHs (Kadota et al., 2014) . Furthermore, S318 and S322 of RBOHC (corresponding to S343 and S347 in RBOHD) are required for ROS production and root hair formation (Takeda et al., 2008) . Together, these results support the idea that these phosphorylation sites play BIK1 phosphorylates both S343 and S347 of RBOHD during PTI, and the bik1 knockout mutant exhibits reduced S343/S347 phosphorylation and PTI-mediated ROS burst (Kadota et al., 2014; Li et al., 2014) . Therefore, we investigated the involvement of BIK1 in ROS production during ETI. We found that BIK1 protein accumulated on infection with Pto DC3000 (avrRpm1) and, to a lesser extent, Pto DC3000 EV (Fig. 5a ). PBS1-LIKE-1 (PBL1) is a kinase functionally redundant with BIK1, and a bik1pbl1 double mutant shows less PAMP-inducible ROS production and RBOHD phosphorylation (J. Zhang et al., 2010; Kadota et al., 2014; Li et al., 2014) . However, bik1pbl1 double mutants induced H 2 O 2 accumulation similar to Col-0 on infection with Pto DC3000 (avrRpm1) (Fig. 5b) , suggesting that BIK1 may not play a major role in RBOHD phosphorylation during ETI. This is consistent with the fact that RPS2 activation did not induce significant phosphorylation at other BIK1-mediated phosphorylation sites, such as S39 and S339, suggesting that other kinases may phosphorylate RBOHD at S343 and S347 during RPS2-mediated ETI. 0 -Diaminobenzidine (DAB)-mediated H 2 O 2 staining in rbohD and rbohD mutants expressing 3xFLAG-RBOHD WT and the S343A/S347A variant 8 h after infiltration with the bacteria. The right halves of the leaves were infiltrated with 10 mM MgCl 2 solution, Pseudomonas syringae pv tomato (Pto) DC3000 EV, Pto DC3000 (avrRpm1) or Pto DC3000 (avrRpt2). We repeated the experiment three times with similar results (four to five leaves per genotype were stained each time).
(a) (b) Fig. 5 The bik1pbl1 double mutant does not exhibit a defect in reactive oxygen species (ROS) accumulation during effector-triggered immunity (ETI). (a) BOTRYTIS-INDUCED KINASE-1 (BIK1) protein accumulates after infection with Pseudomonas syringae pv tomato (Pto) DC3000 (avrRpm1). pBIK1:BIK1-HA plants were inoculated with 5 mM MgCl 2 , Pto DC3000 empty vector (EV) or Pto DC3000 (avrRpm1) (2.5 9 10 7 cfu (colony-forming units) ml
À1
) and BIK1-HA protein amount was determined by immunoblot analyses using anti-HA antibody. Coomassie Brilliant Blue G-250 (CBB) stain shows Rubisco protein to demonstrate equal loading. (b) H 2 O 2 accumulation in Col-0 and bik1pbl1 mutant after inoculation with 10 mM MgCl 2 , Pto DC3000 EV or Pto DC3000 (avrRpm1) (2.5 9 10 7 cfu ml
). H 2 O 2 accumulation was detected by 3,3 0 -diaminobenzidine (DAB). The experiments were performed three times with similar results.
The autoimmunity phenotype of rbohD and semi-dwarf phenotype of rbohDrhohF can be complemented with the RBOHD S343A/S347A variant In addition to a direct toxic effect of ROS to microbial pathogens, the RBOHD-induced ROS burst plays critical roles in immunity, including stomatal closure, which hampers the entrance of pathogens through these pores, callose deposition, which prevents pathogen invasion, and long-distance immune signaling, which induces resistance against secondary infections (Suzuki et al., 2011; Kadota et al., 2015) . However, the role of RBOHD-mediated ROS in resistance against avirulent pathogens is still unclear, mostly because of a lack of genetic evidence. rbohD mutants do not produce ROS on infection with avirulent Pto strains and an avirulent Hpa isolate Emco5 (Torres et al., 2002; Gao et al., 2013) . However, the rbohD and rbohDrbohF double mutants (RBOHF is functionally redundant with RBOHD in many immune responses) are resistant to virulent and avirulent pathogens as a result of the constitutive or inducible activation of immune responses (Torres et al., 2002; Marino et al., 2012) . Notably, rbohD plants hyperaccumulate salicylic acid, ethylene, the antimicrobial compound scopoletin and PR-1 gene transcripts on pathogen challenge (Pogany et al., 2009; Chaouch et al., 2012; Kadota et al., 2014) . Indeed, we observed that rbohD mutants expressed higher amount of transcripts of FERULOYL COA ORTHO-HYDROXYLASE 1 (F6 0 H1), a key enzyme for scopoletin biosynthesis, after infection with Pto DC3000 (avrRpt2) (Fig. 6a) . Interestingly, however, this phenotype was suppressed in rbohD plants expressing the WT or S343A/S347A RBOHD variant, suggesting that the overactivation of immunity in the null rbohD mutant may compensate for the loss of ROS-based immunity. Notably, similar constitutive or overactivation of immunity was seen in null mutants of other positive regulators of immune signaling, such as BAK1, BIK1, POWDERY MILDEW RESISTANT-4 (PMR4) and MITOGEN-ACTIVATED PROTEIN KINASE-4 (MPK4) (Petersen et al., 2000; Nishimura et al., 2003; He et al., 2007; Kemmerling et al., 2007; J. Zhang et al., 2010; Z. Zhang et al., 2012 Z. Zhang et al., , 2017 . A possible explanation is that these components are guarded by NLR proteins, as seen for MPK4 (Z. Zhang et al., 2012) , whose kinase activity on CALMODULIN-BINDING RECEPTOR-LIKE CYTOPLASMIC KINASE 3 (CRCK3) is monitored by NLR protein SUMM2 (Lolle et al., 2017; Z. Zhang et al., 2017) . 0 H1 in leaves infiltrated with Pseudomonas syringae pv tomato DC3000 (avrRpt2) (2.5 9 10 7 cfu (colony-forming units) ml 
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Although the rbohD mutant does not show obvious phenotypes under standard growth conditions, the rbohDrbohF double mutant is semi-dwarf and shows a strong autoimmune phenotype, including the development of necrotic lesions and callose deposition in mature leaves (Torres et al., 2002) . To determine whether S343 or S347 phosphorylation plays a role in this phenotype, we generated rbohDrbohF mutant lines expressing the WT or the S343A/S347A variant of RBOHD at similar levels (Fig. 6b) . Remarkably, the semi-dwarf phenotype of the rbohDrbohF double mutant was recovered by the expression of WT, as well as the expression of the S343A/S347A RBOHD variant (Fig. 6c) , showing that the presence of RBOHD protein, but not phosphorylation at S343 or S347, is required for the normal growth and suppression of autoimmunity in rbohD and rbohDrbohF mutants (Fig. 6c) . These results suggest that the activity of RBOHD is not required for the suppression of autoimmunity and supports a hypothesis in which RBOHD and RBOHF are guarded by one or more NLRs.
RBOHD phosphorylation of S343 or S347 is required for immunity
Although ROS are involved in various immune responses, there is no clear genetic evidence showing the crucial roles of ROS in resistance against avirulent pathogens. As rbohD lines expressing the RBOHD S343A/S347A variant do not show any obvious autoimmune-related phenotypes, we used these lines to study the relevance of S343 and S347 phosphorylation in ETI. Pto DC3000 (avrRpm1) and Pto DC3000 (avrRpt2) grew significantly more in the rbohD mutant expressing the RBOHD S343A/S347A variant than in the mutant expressing WT RBOHD (Fig. 7) , showing that phosphorylation at S343 and S347 is important for resistance against these avirulent bacterial strains.
In addition, we used the rbohDrbohF lines with the RBOHD S343A/S347A variant to test the resistance against the necrotrophic fungus PcBMM. Both RBOHD and RBOHF are required for resistance against PcBMM, as the rbohDrbohF mutant was shown to display enhanced susceptibility to PcBMM (Torres et al., 2013; Morales et al., 2016) . As reported, Col-0 and phosphorylation sites S343 and S347 are required for effector-triggered immunity (ETI). Bacterial growth of Pseudomonas syringae pv tomato (Pto) DC3000 (avrRpm1) (a) and Pto DC3000 (avrRpt2) (b) in rbohD and rbohD expressing 3xFLAG-RBOHD wild-type (WT) or the S343A/S347A variant. Bacteria were syringe infiltrated in three leaves per plant at a concentration of 1 9 10 5 cfu (colony-forming units) ml WT RBOHD complementation lines were resistant to PcBMM (Fig. 8) . By contrast, rbohDrbohF and RBOHD S343A/S347A plants were significantly more susceptible, similar to the agb1 mutant (impaired in the Gb subunit of the heterotrimeric G protein), which is a susceptible control (Torres et al., 2013) (Fig. 8) . These results suggest that the RBOHD residues S343 and S347 contribute to the resistance against PcBMM. The rbohD single mutants and the corresponding complementation lines were all resistant to PcBMM (Fig. S5) , indicating that RBOHF has a functional redundancy with RBOHD in immunity against PcBMM. The importance of S343 and S347 in the resistance suggests that plants actively phosphorylate RBOHD and produce ROS in response to PcBMM, possibly through the recognition of unidentified PAMPs or damage-associated molecular patterns (DAMPs). The result also suggests that the susceptibility of rbohDrbohF is probably not a result of the overactivation of the salicylic acid-dependent pathway, which antagonizes jasmonic acid-based resistance against necrotrophic pathogens (Thaler et al., 2012) , but of the loss of RBOHD activation and ROS production.
Discussion
RPS2 and FLS2 trigger similar phosphorylation patterns at immune components
Previous studies have shown that similar responses are induced during PTI and ETI, although the dynamics and amplitude differ between the two signaling arms (Dodds & Rathjen, 2010; Tsuda & Katagiri, 2010; Thomma et al., 2011) . Our study reveals a common set of differentially phosphorylated sites during both PTI and ETI. Such common sites may be convergent points of both signaling pathways, and phosphorylation or dephosphorylation of such residues probably plays a crucial role in regulating the activity of defense components. In support of this, we found that phosphorylation at specific conserved residues in RBOHD is required for ROS production in both PTI and ETI. In addition, we found commonly phosphorylated sites during PTI and ETI in PEN3 and ACA8. Importantly, previous mutational analyses have shown that these phosphorylation sites of PEN3 and ACA8 are required for their activation (Giacometti et al., 2012; Underwood & Somerville, 2017) .
We also found a commonly dephosphorylated site, T948 on AHA1, during PTI and ETI. Phosphorylation at T948 of AHA1 creates a binding site for a 14-3-3 protein, and 14-3-3 interaction alters the orientation of the autoinhibitory C-terminal domain, resulting in AHA1 activation (Svennelid et al., 1999) . Thus, dephosphorylation of AHA1 at T948 would cause dissociation of 14-3-3, leading to the inactivation of AHA1. AHA1 inactivation may lead to the inhibition of stomatal opening, thereby preventing bacterial entry (Yamauchi et al., 2016) .
Which kinases phosphorylate such common sites? Candidates include CPKs which play critical roles during PTI and ETI (Boudsocq et al., 2010; Gao et al., 2013) . Indeed, some of our identified common sites contain a CPK phosphorylation motif (S347 of RBOHD, S40 of PEN3 and S22 of ACA8, Tables S1-S3 ). In particular, CPK10 was shown to phosphorylate synthetic peptides carrying S45 of PEN3 in vitro (Curran et al., 2011) , and CPK16 phosphorylates S22 of ACA8 in vitro (Giacometti et al., 2012) . However, the involvement of CPK10 and CPK16 in PTI and ETI is unknown. CPK4/5/6/11 have been shown to be required for the PAMP-inducible ROS burst (Boudsocq et al., 2010; Dubiella et al., 2013) , and CPK1/2 have been shown to be required for full activation of the RPM1-and RPS2-mediated ROS burst (Gao et al., 2013) , suggesting the involvement of these CPKs in the phosphorylation of RBOHD during both PTI and ETI. CPK4/5/6/11 phosphorylate RBOHD at S163 and S347 in vitro, and these sites also encompass a CPK phosphorylation motif (Kadota et al., 2014) . CPK 2/4/11 also phosphorylate RBOHD at S148 in vitro (Gao et al., 2013) , but it is unknown whether CPK1/2 phosphorylate S163 and S347 in vitro or during ETI. The accumulating evidence suggests that multiple CPKs are involved in the phosphorylation of RBOHD and other defense components during PTI and ETI. However, as CPKs are unable to phosphorylate S343 (which does not possess a CPK phosphorylation motif) in vitro (Kadota et al., 2014) , it is likely that there are other kinase(s) that phosphorylate RBOHD during ETI (Fig. S6) .
During PTI, the RLCK BIK1 phosphorylates RBOHD at residues S343 and S347 (Kadota et al., 2014; Li et al., 2014) . This suggests that BIK1 or similar RLCKs might phosphorylate RBOHD during ETI. However, there is no current experimental evidence showing the involvement of BIK1 in ETI. Our data show that the bik1pbl1 mutant does not affect RBOHDmediated ROS production during ETI (Fig. 5) . It is possible that other RLCKs act redundantly with BIK1 and PBL1 in the phosphorylation of RBOHD at S343 and S347 during ETI. Notably, RPS2 activation by AvrRpt2 induces the accumulation of many RLCKs, including BIK1, PBL2, PBL32 and RIPK, at 6 h after Dex treatment in Dex:avrRpt2 plants (Elmore et al., 2012) . RPS2 activation by AvrRpt2 also induces the phosphorylation of RIPK at 3 h post-Dex treatment (Fig. 2) , suggesting the possible involvement of RIPK in RPS2 signaling. It would be interesting to investigate the involvement of these RLCKs in RBOHD phosphorylation using multiple knockout mutants. Interestingly, the MAP4 kinase SIK1 has been found recently to be able to phosphorylate RBOHD during PTI (M. Zhang et al., 2018) . However, it remains to be elucidated whether SIK1 contributes to RBOHD phosphorylation during ETI.
MPK3 and MPK6 play critical roles in PTI and ETI signaling, and it is likely that these MPKs phosphorylate similar downstream proteins during PTI and ETI (Tsuda et al., 2013; Su et al., 2018) . Examples of such proteins are WRKY transcription factors and 1-AMINO-CYCLOPROPANE-1-CARBOXYLIC ACID SYNTHASES (ACSs), which are the key enzymes of the ethylene biosynthesis pathway (Liu & Zhang, 2004; Adachi et al., 2015; Sheikh et al., 2016) . In addition, in our dataset, for example, residues S63 of PEARLI4 and T336 of the CBS domain-containing protein contain an S/T-P MPK phosphorylation motif (Tables 1, S4 ). Hence, it is likely that MPKs, such as MPK3 and MPK6, phosphorylate these sites (Sorensson et al., 2012) . (Pecher et al., 2014) . We found increased phosphorylation of S/T-P site S194 after activation of RPS2 (Table S1) . Although direct evidence is not present, it is tempting to speculate that MVQ1 is phosphorylated during PTI and ETI by MPK3 and MPK6 to regulate WRKY-mediated gene expression.
The kinases phosphorylating common PTI and ETI phosphorylation sites in vivo are still largely unknown. The identification of these kinases is important in our understanding of how different receptors, localized to different cellular compartments, regulate the same defense components. Moreover, clarification of their activation mechanisms may further explain the commonalities and differences in PTI and ETI signaling. For example, differences in the dynamics and strength of kinase activation during PTI and ETI may cause differential phosphorylation dynamics of the defense components and subsequent immune signaling outputs (Tsuda et al., 2013) .
RPS2-regulated phosphorylation sites
In addition to common PTI and ETI phosphorylation sites, we identified undiscovered and novel phosphosites involved in RPS2 signaling. Some of these sites are located on important immune components, including PIP aquaporins. However, the kinases and phosphatases directly phosphorylating and dephosphorylating RPS2-regulated phosphosites remain largely unknown. CPKs and MPKs are strong candidate kinases for the phosphorylation of these sites because many RPS2-regulated phosphorylation sites contain CPK and/or MAPK phosphorylation motifs (Table S1 ). Some CPKs, including CPK1, phosphorylate synthetic peptides carrying S282 of PIP2D and T279 of PIP3 in vitro, both of which are RPS2-regulated phosphosites (Curran et al., 2011) . Further evidence comes from the RPS2-upregulated phosphosites, S11 of CALCIUM-BINDING EF-HAND FAMILY PROTEIN (AT2G41410) and S238 of ADAPTIN EAR-BINDING COAT-ASSOCIATED PROTEIN-1 (NECAP-1), which contain an S/T-P motif (Table S1 ). In addition, their phosphorylations were identified in planta after activation of MPK3/MPK6 by the expression of a constitutively active MEK DD mutant protein (Hoehenwarter et al., 2013) . This suggests the possible involvement of MPK3/MPK6 in the phosphorylation of these residues. The identification and characterization of kinases and phosphatases regulating RPS2 signaling components, in addition to mutational analyses of the corresponding phosphorylation sites, would aid in the resolution of the RPS2 signaling network at the molecular level.
RBOHD-mediated ROS production is crucial for ETI
Our study revealed that RBOHD-mediated ROS production is required for resistance against avirulent bacteria, and thus for successful ETI. We also found that RBOHD-mediated ROS contributes to the resistance against a virulent fungus. A remaining question is how ROS contributes to the resistance against these pathogens. Although ROS are believed to be directly toxic to pathogens (Lambeth, 2004) , they are also likely to function as signaling molecules to change the redox status and affect the enzymatic activities and gene expression. In this context, it is interesting that PIPs, which transport H 2 O 2 to the cytoplasm (Maurel et al., 2015) , are phosphorylated at activation sites during ETI (Figs 2, S3b; Table S4 ). This suggests that plants regulate the import of H 2 O 2 produced via RBOHD, thereby actively altering the cellular redox status on ETI. In addition, the import of H 2 O 2 through PIPs during ETI might, for example, induce stomatal closure, as these components play critical roles in stomatal closure (Kwak et al., 2003; Mersmann et al., 2010; Rodrigues et al., 2017) . Taken together, our data suggest that plants activate ROS production and ROS-mediated signaling occurs in large part by protein phosphorylation.
Final remarks
In summary, our study provides the first large-scale phosphoproteomic data of NLR-mediated ETI, adding important pieces to our understanding of the ETI signaling network. Among the identified differential phosphorylation sites, we found phosphorylation sites common to PTI and ETI signaling on a number of important defense-related proteins. Some of these phosphorylation sites play critical roles in the activation or inactivation of the corresponding proteins, and thereby mediate immune signaling. The observations made in this study enhance our understanding of immune signaling regulation during ETI and PTI. The future identification of proteins regulating the common phosphorylation sites, such as kinases, will further clarify the commonalities and differences of ETI and PTI at the molecular level.
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